Below are the most recent publications written about "Liposomes" by people in Profiles.
-
Kashikar R, Kotha AK, Shrestha R, Channappanavar R, Chougule MB. Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection. AAPS PharmSciTech. 2025 May 16; 26(5):139.
-
Balcorta HV, Mata Corral MY, Gallegos A, Chavez J, Perez J, Balivada S, Natividad-Diaz SL, Poon W. Development of Chemical Tags for Universal Lipid Nanoparticle Visualization and Tracking in 2D and 3D Imaging. Nano Lett. 2025 05 14; 25(19):7682-7689.
-
Yi S, Noh K, Kim H, Jung E, Kim S, Lee J, Guk K, Choi J, Lim EK, Kim S, Park H, Lim JH, Jung CR, Kang T, Jung J. Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. Mol Cancer. 2025 Apr 24; 24(1):124.
-
Shin HE, Giannakopoulos S, Park JD, Jang HJ, Park CG, Murphy SV, Park J, Verma S, Park W. Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation. J Control Release. 2025 Jun 10; 382:113736.
-
Gangavarapu A, Tapia-Lopez LV, Sarkar B, Pena-Zacarias J, Badruddoza AZM, Nurunnabi M. Lipid nanoparticles for enhancing oral bioavailability. Nanoscale. 2024 Oct 10; 16(39):18319-18338.
-
Diwan R, Bhatt HN, Dong R, Estevao IL, Varela-Ramirez A, Nurunnabi M. Cell selective BCL-2 inhibition enabled by lipid nanoparticles alleviates lung fibrosis. J Control Release. 2024 Jun; 370:421-437.
-
Bhatt HN, Diwan R, Estevao IL, Dong R, Smith J, Xiao C, Agarwal SK, Nurunnabi M. Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis. J Control Release. 2024 Jun; 370:110-123.
-
Bashi A, Lekpor C, Hood JL, Thompson WE, Stiles JK, Driss A. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease. Int J Mol Sci. 2023 Nov 29; 24(23).
-
Ndemazie NB, Bulusu R, Zhu XY, Frimpong EK, Inkoom A, Okoro J, Ebesoh D, Rogers S, Han B, Agyare E. Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. Int J Mol Sci. 2023 Feb 21; 24(5).
-
Skelton R, Roach A, Prudhomme LE, Cen Feng JYC, Gaikwad P, Williams RM. Formulation of Lipid-Free Polymeric Mesoscale Nanoparticles Encapsulating mRNA. Pharm Res. 2022 Nov; 39(11):2699-2707.